Log In
Print
BCIQ
Print
Print this Print this
 

Entereg, alvimopan

Also known as: ADL 8-2698

  Manage Alerts
Collapse Summary General Information
Company Cubist Pharmaceuticals Inc.
DescriptionMu opioid receptor (OPRM1; MOR) antagonist
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPost-operative ileus
Indication DetailsTreat post-operative ileus (POI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today